S
Shekhar M. Kumta
Researcher at The Chinese University of Hong Kong
Publications - 115
Citations - 3543
Shekhar M. Kumta is an academic researcher from The Chinese University of Hong Kong. The author has contributed to research in topics: Giant-cell tumor of bone & Stromal cell. The author has an hindex of 31, co-authored 110 publications receiving 3186 citations. Previous affiliations of Shekhar M. Kumta include University of Hong Kong & Hospital Authority.
Papers
More filters
Journal ArticleDOI
Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: A case-control study
TL;DR: Clinical use of bisphosphonates as an adjuvant therapy for giant cell tumor of bone demonstrated a lower local recurrence rate and the clinical response seems to be more promising in stage III diseases.
Journal ArticleDOI
One-step reconstruction with a 3D-printed, biomechanically evaluated custom implant after complex pelvic tumor resection
TL;DR: A novel CT-based method for surgical planning, the engineering software for implant design and validation, together with 3D printing technology for implant and PSI fabrication makes it possible to generate a personalized, biomechanically evaluated implant for accurate reconstruction after a pelvic tumor resection in a one-step operation.
Journal ArticleDOI
Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids.
James F. Griffith,Gregory E. Antonio,Shekhar M. Kumta,David S.C. Hui,Jeffrey K.T. Wong,Gavin M. Joynt,Alan Ka Lun Wu,Albert Yu Kiu Cheung,Kwok Hing Chiu,Kai-Ming Chan,Ping-Chung Leung,Anil T. Ahuja +11 more
TL;DR: An appreciable dose-related risk was found for osteonecrosis in patients receiving steroid therapy for SARS and results of multiple logistic regression analysis confirmed cumulative prednisolone-equivalent dose to be the most important risk factor for oste onecrosis.
Journal ArticleDOI
The effect of hyaluronan on osteoblast proliferation and differentiation in rat calvarial‐derived cell cultures
TL;DR: The findings suggest that HA has a molecular weight-specific and dose-specific mode of action that may enhance the osteogenic and osteoinductive properties of bone graft materials and substitutes due to its stimulatory effects on osteoblasts.
Journal ArticleDOI
Expression of VEGF and MMP-9 in giant cell tumor of bone and other osteolytic lesions.
TL;DR: VEGF and MMP-9 expression in osteolytic lesions of bone co-relates well with the extent of bone destruction and local recurrence, and may provide some prognostic indication of the possible aggressive behavior of the underlying pathology.